NCT02777008View on ClinicalTrials.gov

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Healthy
Interventions
DRUG

CTP-543

DRUG

Placebo for CTP-543

Trial Locations (1)

5000

Adelaide

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT02777008 - Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects | Biotech Hunter | Biotech Hunter